Intrahepatic Cholangiocarcinoma  >>  Caprelsa (vandetanib)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Caprelsa (vandetanib) / Sanofi
VANGOGH, NCT00753675 / 2007-003056-12: Vandetanib Gemcitabine Or Placebo Plus Gemcitabine Or Vandetanib Monotherapy In Advanced Biliary Tract Cancer

Completed
2
174
Europe
ZD6474, Vandetanib, Zactima, Gemcitabine, Gemzar, Placebo matching ZD6474
Genzyme, a Sanofi Company
Biliary Tract Cancer, Gallbladder Cancer, Cancer Of The Extrahepatic Bile Duct, Ampullary Carcinoma
09/12
09/12

Download Options